ArticleProceedings of the National Academy of Sciences of the United States of America2023

Losartan controls immune checkpoint blocker-induced edema and improves survival in glioblastoma mouse models.

Meenal Datta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.